Hillsdale Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.91M Buy
463,340
+12,930
+3% +$269K 0.27% 59
2025
Q4
$9.63M Sell
450,410
-1,790
-0.4% -$36.7K 0.27% 61
2025
Q3
$7.57M Buy
452,200
+75,700
+20% +$1.13M 0.23% 99
2025
Q2
$5.4M Buy
376,500
+376,000
+75,200% +$5.16M 0.2% 148
2025
Q1
$7.25K Hold
500
﹤0.01% 508
2024
Q4
$6.56K Buy
+500
New +$6.9K ﹤0.01% 543
2019
Q1
Sell
-7,970
Closed -$263K 650
2018
Q4
$263K Buy
7,970
+170
+2% +$6.83K 0.03% 383
2018
Q3
$364K Buy
7,800
+1,000
+15% +$45.9K 0.05% 242
2018
Q2
$294K Buy
+6,800
New +$326K 0.04% 286
2016
Q1
Sell
-4,700
Closed -$337K 525
2015
Q4
$337K Buy
4,700
+800
+21% +$59.2K 0.13% 226
2015
Q3
$299K Sell
3,900
-500
-11% -$40.3K 0.1% 204
2015
Q2
$326K Buy
+4,400
New +$317K 0.1% 212

Other funds holding MD

Hillsdale Investment Management's MD Position: Q1 2026 in Review

Hillsdale Investment Management increased its Pediatrix Medical (MD) stake by 2.9% in Q1 2026, buying an estimated $269K and bringing the position to 463,340 shares worth $9.91M. The position accounts for 0.27% of the portfolio, ranked #59.

Hillsdale Investment Management first reported a position in MD in Q2 2015 and has held it in 12 quarters since. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Hillsdale Investment Management held 463,340 shares of Pediatrix Medical worth $9.91M as of Q1 2026.
  • Hillsdale Investment Management bought 12,930 Pediatrix Medical shares in Q1 2026, an estimated $269K.
  • Pediatrix Medical made up 0.27% of Hillsdale Investment Management's portfolio in Q1 2026, its #59 holding.
  • Hillsdale Investment Management first reported a position in Pediatrix Medical in Q2 2015 and has held it in 12 quarters since.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.